http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-797200-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-513
filingDate 1956-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1958-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-797200-A
titleOfInvention Manufacture of unsaturated aldehydes
abstract The invention comprises 4-[21,61,61-trimethyl cyclohexadien - (11,31) - yl - (11)] - 2 - methy - buten-(2)-al-(1) and a method of making it and also [2,6,6 - trimethyl - cyclohexen - (1) - yl-(1)]-acetaldehyde, [2,6,6 - trimethyl - cyclohexadien-(1,3) - yl - (11)] - acetaldehyde and 4 - [21,61,61-trimethyl - cyclohexen - (11) - yl - (11)] - 2 - methyl-buten - 2 - al - (1) by acetalising [2,6,6 - tri - methyl - cyclohexylidene - (1)] - acetaldehyde or 4 - [21,61,61 - trimethyl - cyclohexylidene - (11)]-2-methyl - buten - (2) - al - (1) or either of the corresponding compounds containing a double bond in 2,3-position of the cyclohexylidene radical by treating the same with a trialkyl ester of an orthoalkanoic acid in presence of an acid condensing agent, splitting off one mol. alcohol from the acetal so obtained by heating with an acidic agent in presence of a tertiary base to give an enol-ether, and hydrolysing the enol-ether under acid conditions. Orthoformic ethyl ester may be the orthoalkanoic ester, and acid condensing agents specified are boron trifluoride etherate, zinc chloride, ammonium nitrate, phosphoric acid, or p-toluene sulphonic acid. The splitting off of alcohol may be accomplished with phosphorus pentoxide, phosphorus oxychloride, or acetic anhydride in presence of an organic base. Examples describe (A) the acetalisation of each of the four starting materials with orthoformic ethyl ester in ethanol in presence of phosphoric acid to give 1,1 - diethoxy - 2 - [21,61,61 - trimethyl - cyclo-hexylidene - (11)] - ethane, 1,11 - diethoxy - 2 - [21,61,61 - trimethyl - cyclohexen - (21) - ylidene - (11)] - ethane, 1,1 - diethoxy - 4 - [21,61,61 - trimethyl - cyclohexylidene - (11)] - 2 - methyl-butene - (2), and 1,1 - diethoxy - 4 - [21,61,61 trimethyl - cyclohexen - (21) - ylidene - (11)] - 2 - methyl-butene-(2), (B) the treatment of these acetals with phosphorus oxychloride or acetic anhydride and pyridine in toluene (together with p-toluene-sulphonic acid when acetic anhydride is used) to give the enol-ethers 1 - ethoxy - 2 - [21,61,61 - trimethyl - cyclohexen - (11) - yl - 11] ethylene, 1 - ethoxy - 2 - [21,61,61 - trimethyl - cyclohexadien - (11,31) - yl - (11)]-ethylene, 1 - ethoxy - 4 - [21,61,61 - trimethyl-cyclohexen - (11) - yl - (11)] - 2 - methyl - buta-diene - 1,3, 1 - ethoxy - 4 - [21,61,61 - trimethyl-cyclohexadien - (11,31) - yl - (11)] - 2 - methyl-butadiene-(1,3), and (3) the hydrolysis of these enol-ethers with sulphuric, phosphoric, or p-toluene sulphonic acid in aqueous-alcoholic solution. [2,6,6 - Trimethyl - cyclohexylidene-(1)] - acetaldehyde and [2,6,6 - trimethyl-cyclohexen - (2) - ylidene - (1)] - acetaldehyde are prepared from 2,6,6-trimethyl-cyclohexanone and 2,6,6 - trimethyl - cyclohexen - (2) - one-(1) by condensation with b -chlorvinyl ether in liquid ammonia in presence of lithium, followed by hydrogenation. Alkyl radicals concerned above contain 1-6 carbon atoms. Specifications 773,863, 789,693 and 797,201 are referred to.
priorityDate 1955-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449957047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414881231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3013896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3028194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450459896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416217425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448605289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409432392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118

Total number of triples: 54.